Khaitan & Co advises Capillary Tech on DRHP filing

Khaitan & Co advised Capillary Technologies India Limited and its Promoter Selling Shareholder, Capillary Technologies International Pte. Ltd., on the filing of the draft red herring prospectus for the company’s proposed initial public offering (IPO).

The IPO comprises a fresh issue of equity shares aggregating up to ₹430 crore and an offer for sale of up to 18,331,386 equity shares of face value ₹2 each.

The transaction team consisted of Sudhir Bassi (Executive Director - Capital Markets), Thomas George (Partner), Poorvi M Jain (Principal Associate), Jash Botadra (Associate), Sanjeev Ramakrishnan (Associate), Anand Sivasankaran (Associate).

Proceeds from the fresh issue are earmarked primarily for cloud infrastructure (₹120 cr), product R&D (₹151.54 cr), purchase of computer systems (₹10.32 cr), with the remainder reserved for potential acquisitions and general corporate purposes.

The IPO is being managed by JM Financial, IIFL Capital, and Nomura, and marks Capillary’s second attempt to go public, having shelved an earlier plan in 2021

Founded in 2012, Capillary Technologies offers a comprehensive suite of solutions designed to help businesses boost customer retention, engagement, and revenue. Their platform provides a unified view of customers across all channels, enabling brands to deliver personalized experiences and build stronger relationships.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.